Precigen, Inc. - Common Stock (PGEN)

Precigen Inc is a biotechnology company focused on developing innovative gene and cell therapies aimed at addressing a range of diseases, including cancer and genetic disorders

The company leverages its proprietary technologies to create advanced therapeutic solutions that aim to enhance the body's immune response and provide targeted treatment options. By utilizing its expertise in genetic engineering and immunology, Precigen works to bring transformative health solutions to patients while advancing the field of precision medicine.